Deadline: May 27, 2024 QA Specialist


Pharmacosmos is seeking a competent new colleague to join our QA team in a dynamic and growing company. We are 15 employees in QA, responsible for ensuring GMP compliance and oversight in relation to development, manufacturing and distribution of APIs and drug product. We have close cooperation with many different parties - internally and externally - which provides a variety in the daily tasks.


As QA Specialist, you will be part of our highly dedicated team consisting of 5 colleagues working with a broad range of QA tasks such as batch review, processing of complaints, deviations and change requests as well as validation and ad hoc projects.


  • Pharmacist, Engineer or have similar master’s degree
  • A strong quality mindset
  • Works independently, analytically, and systematically, but also in a collaborative approach
  • Highly motivated for solving tasks at a high and competent level
  • Strong communication skills and fluent in Danish and English


You have a good knowledge of GMP and GDP, minimum 5 years of relevant experiences from pharma business and QA, and preferably within one or more of the following areas:

  • Aseptic manufacturing/production of sterile drug products
  • Manufacturing of API
  • Batch review
  • Validation tasks
  • Quality control
  • Complaint handling
  • Change control
  • Risk Management/Risk Assessment

how to apply

Apply for the job and send your CV and motivation using the link in the top right side. 

If you have any questions about this job before applying, please contact:

Rikke Sejer
Quality Assurance Director
T: +45 2565 9554

Please note that all enquiries will be handled with confidentiality.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.

About Monofer®

Monofer® (ferric derisomaltose) is an iron-carbohydrate complex for intravenous administration. Monofer® is marketed in more than 30 countries worldwide for the treatment of iron deficiency and iron deficiency anaemia. Monofer® is manufactured by Pharmacosmos A/S, Denmark.


Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt


Please identify if you are a: